Bhadmus Mariam: A Rising Nigerian Scientist Leading the Fight Against Tuberculosis

Today marks World TB Day, a moment not just for reflection, but for renewed commitment, collective responsibility, and decisive action in the global fight against tuberculosis (TB).

Tuberculosis remains the world’s leading infectious killer, responsible for more than 1.2 million deaths annually. Despite significant advances in diagnostics and treatment, the disease continues to disproportionately burden low and middle-income countries, where access to healthcare, early detection, and treatment adherence remain persistent challenges.

This year’s theme, “Yes! We Can End TB: Led by countries. Powered by people,” underscores a critical truth: eliminating TB is not the responsibility of governments or scientists alone. It requires a coordinated effort across all levels of society, from policymakers and healthcare professionals to researchers and local communities.

While progress has been made, the limitations of current TB treatments cannot be ignored. Existing drug regimens are lengthy, often associated with significant side effects, and increasingly challenged by the rise of drug-resistant strains. These realities highlight an urgent need for innovation in three key areas: the discovery of new drug targets to outpace resistance, the development of shorter and more effective treatment regimens, and sustained investment in TB research.

At the forefront of this effort is Bhadmus Mariam, a Nigerian scientist currently pursuing her doctoral studies at the University of Huddersfield. She earned her first degree in Biochemistry from the Federal University of Agriculture Abeokuta and later obtained a Master’s degree in Biomedical and Analytical Science from the University of Huddersfield.

Her PhD research focuses on identifying novel drug targets from previously uncharacterised Mycobacterium tuberculosis P450 enzymes. By investigating how these enzymes function and contribute to the pathogen’s ability to evade the human immune system, her work aims to support the development of more effective and targeted TB treatments.

For Mariam, this research is more than an academic pursuit. Tuberculosis remains a significant public health challenge in Nigeria, where many people continue to lose their lives due to limited access to treatment and the difficulty of completing long and demanding drug regimens. This reality underscores the urgency of her work and its potential impact on vulnerable populations.

Organizations such as the World Health Organization and the Nigeria Centre for Disease Control continue to play critical roles in coordinating global and national responses. However, sustained progress will depend on increased investment in research, stronger healthcare systems, and greater community awareness.

Ending TB is within reach, but only if urgency replaces complacency. The science is advancing, the tools are improving, and researchers like Bhadmus Mariam are contributing to the global effort to outpace this disease.

On this World TB Day, the message is clear: defeating tuberculosis will require a united front. Governments must prioritise funding, researchers must continue to innovate, healthcare workers must be empowered, and communities must remain informed and engaged.

Yes, we can end TB. But only if we act—together.